Risks factors and prevention of Q fever endocarditis

Clinical Infectious Diseases

Volumn 33, Issue 3, 2001, Pages 312-316

  Fenollar, Florence ^a   Fournier, Pierre Edouard ^a   Carrieri, M Patrizia ^b   Habib, Gilbert ^c   Messana, Thierry ^c   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Institut Nationale de Santé   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; HYDROXYCHLOROQUINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXIELLA BURNETII; DRUG EFFICACY; ENDOCARDITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q FEVER; RISK FACTOR; RISK MANAGEMENT; TREATMENT INDICATION; VALVULAR HEART DISEASE;

AGED; ANTI-INFECTIVE AGENTS; DOXYCYCLINE; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HUMANS; HYDROXYCHLOROQUINE; MALE; MIDDLE AGED; Q FEVER; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034928070     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321889     Document Type: Article

References (37)

1. Q fever
2. Chronic Q fever: Ninety-two cases from France, including 27 cases without endocarditis
3. Q fever endocarditis in England and Wales, 1975-81
4. Diagnosis of Q fever
5. Chronic Q fever: Diagnosis and follow up
6. Acute and chronic Q fever in patients with cancer
7. Q fever and HIV infection
8. Q fever endocarditis
9. Coxiella burnetii: The "query" fever bacterium, a model of immune subversion by a strictly intracellular microorganism
10. Long-term persistence of Coxiella burnetii in the host after primary Q fever
11. Serological evaluation of Q fever in humans: Enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis
12. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis
13. Q fever serology: Cutoff determination for microimmunofluorescence
14. Correlation of plasmid type and disease caused by Coxiella burnetii
15. Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates
16. The role of lipopolysaccharides in the virulence of Coxiella burnetii
17. Cellular immunity in Q fever: Specific lymphocyte unresponsiveness in Q fever endocarditis
18. Host factors in the severity of Q fever
19. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: The Coxiella burnetii paradigm
20. Studies of latent Q fever infections. I. Effects of whole body X irradiation upon latent Q fever by injected guinea pigs, white mice, and deer mice
21. Studies of latent Q fever infections. I. Effects of multiple cortisone injections
22. d) mice infected with the Nine Mile isolate of C. burnetii
23. Experimental Q fever infection in congenitally athymic nude mice
24. A guinea pig model for Q fever endocarditis
25. Q fever 1985-1998: Clinical and epidemiological features of 1383 infections
26. Quiescent Q fever endocarditis exacerbated by cardiac surgery and corticosteroid therapy
27. Q fever during pregnancy: A risk for women, fetuses, and obstetricians
28. Q fever: Still a query after all these years
29. Subacute rickettsial endocarditis: An unusual complication of Q fever
30. A comparison of Q fever endocarditis with native valve endocarditis
31. Q fever endocarditis
32. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota
33. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs
34. Long term vascular complications of Coxiella burnetii infection in Switzerland: Cohort study
35. Treatment of Q fever endocarditis
36. Q fever endocarditis in Queensland
37. Q fever